Berkshire Hathaway’s Bristol-Myers Squibb BMY Stock Holding History

Berkshire Hathaway’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,202,674	Closed	-$324M	–	51
2021 Q4	$324M	Sell	5,202,674 -16,844,262	-76%	-$988M	0.1%	31
2021 Q3	$1.3B	Sell	22,046,936 -4,247,330	-16%	-$280M	0.44%	22
2021 Q2	$1.76B	Sell	26,294,266 -4,737,961	-15%	-$309M	0.6%	20
2021 Q1	$1.96B	Sell	31,032,227 -2,303,789	-7%	-$143M	0.72%	17
2020 Q4	$2.07B	Buy	33,336,016 +3,364,822	+11%	+$207M	0.77%	18
2020 Q3	$1.81B	Buy	+29,971,194	New	+$1.8B	0.77%	19

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Berkshire Hathaway's BMY Position: Q1 2022 in Review

Berkshire Hathaway sold out of Bristol-Myers Squibb (BMY) in Q1 2022, closing a stake of 5,202,674 shares — an estimated $324M sold.

Berkshire Hathaway first reported a position in BMY in Q3 2020 and held it in 6 quarters. The position peaked at $2.07B in Q4 2020. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

Berkshire Hathaway reported no remaining Bristol-Myers Squibb position as of Q1 2022 after selling out during the quarter.
Berkshire Hathaway sold 5,202,674 Bristol-Myers Squibb shares in Q1 2022, an estimated $324M.
Berkshire Hathaway first reported a position in Bristol-Myers Squibb in Q3 2020 and held it in 6 quarters.
Berkshire Hathaway's Bristol-Myers Squibb position peaked at $2.07B in Q4 2020.
2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on Berkshire Hathaway's 13F filing for Q1 2022, filed 16 May 2022.